Here is a detailed explanation of Lecture 17, which covers three major microbiology topics: Retroviruses/HIV/AIDS, Herpesviruses, and Prion Diseases. The lecture is from a Gene, Cell and Tissue IV - Microbiology course and spans 69 slides.
Lecture 17: Retroviruses, HIV & AIDS, Herpesviruses, and Prions
PART 1: RETROVIRUSES (Slides 1-5)
What Are Retroviruses?
Retroviruses are a unique family of viruses with the following key features:
- Enveloped virus (surrounded by a lipid membrane)
- Single-stranded, positive-sense RNA genome
- Carry reverse transcriptase, an enzyme that converts their RNA into DNA (hence "retro" - they go backward from the central dogma of molecular biology)
- Their DNA integrates into the host genome, becoming a permanent part of the host cell
The Lysogenic Analogy
Just as a lysogenic bacteriophage can be "induced" to replicate by UV radiation or chemicals, retroviruses can similarly be induced by several mechanisms to become active.
Nobel Prize Connection (Slide 4)
The 1975 Nobel Prize in Physiology or Medicine was awarded to Howard Temin, David Baltimore, and Renato Dulbecco for their discoveries about how tumor viruses interact with the genetic material of the cell - specifically the discovery of reverse transcriptase.
How Retroviruses Cause Tumors (Slide 5)
There are two mechanisms:
| Type | Mechanism | Speed |
|---|
| Acute transforming viruses | Carry oncogenes within their RNA genome; can transform cells in culture; may be replication competent or defective | Fast |
| Non-acute (chronic) transforming viruses | Don't carry oncogenes; insert DNA near a proto-oncogene, abnormally activating it and causing uncontrolled division | Slow (1-2 years in animals) |
PART 2: HIV & AIDS (Slides 6-18)
Overview (Slide 6)
- HIV (Human Immunodeficiency Virus) causes AIDS (Acquired Immunodeficiency Syndrome)
- HIV is a retrovirus, a member of the Lentivirus genus
- Two types: HIV-1 (more common globally) and HIV-2 (mainly West Africa), distinguished by genome organization and phylogenetic relationships
Transmission (Slides 7 & 10)
HIV is transmitted via:
- Sexual contact (most common route)
- Parenteral - contaminated blood or blood products (e.g., sharing needles)
- Vertical (mother-to-child):
- Through sperm or egg
- Across the placenta
- In breast milk
- Highest HIV titers are found in blood and semen
Structure (Slide 8)
All retroviruses share the same structural organization. Their genome follows the order:
gag - pol - env
- gag: encodes structural proteins (capsid, matrix)
- pol: encodes enzymes (reverse transcriptase, integrase, protease)
- env: encodes envelope glycoproteins
The HIV Replication Cycle (Slide 9)
- HIV enters the host cell (binds CD4 receptor)
- Viral RNA is released into cytoplasm
- Reverse Transcriptase converts: RNA → DNA
- Viral DNA enters the nucleus
- Viral DNA integrates into host genome (becomes a "provirus")
- Host machinery produces viral RNA and proteins
- New viruses are assembled and released
Dissemination & Timeline (Slide 11)
HIV disease progression follows predictable stages:
- Primary infection - acute flu-like illness
- Dissemination of virus to lymphoid organs (lymph nodes, spleen)
- Clinical latency - asymptomatic but virus still replicating
- Elevated HIV expression - viral load rises
- Clinical disease and death
Average time from primary infection to clinical disease: ~10 years (untreated). Death usually occurs within 2 years after onset of symptoms.
Pathogenesis (Slide 12)
HIV infection is characterized by:
- Inefficient initial transmission (common via sexual contact)
- Acute phase - intense viral replication; antiretroviral syndrome (flu/mono-like illness)
- Activation of innate and adaptive immunity, but the immune system cannot contain the rapidly mutating virus
- Chronic asymptomatic phase (clinical latency) - continued replication
- Advanced phase - marked depletion of CD4+ T lymphocytes → AIDS and opportunistic infections
Target Cells (Slide 13)
- HIV primarily infects and kills CD4+ helper T cells → suppression of cell-mediated immunity
- Also infects brain monocytes and macrophages → forms multinucleated giant cells → central nervous system (CNS) symptoms
Diagnosis (Slide 17)
| Test | Details |
|---|
| ELISA (screening) | Detects antibodies to p24 protein; some false-positives |
| Western blot | Confirmatory test after positive ELISA |
| OraQuick | Rapid home oral-swab screening test; results in 20 minutes; positives require Western blot confirmation |
| Early infection | Antibody tests may be negative for first ~month (window period); average seroconversion = 10-14 days |
Treatment (Slide 18)
- Goals: (1) Restore immune function by raising CD4 count; (2) Reduce viral load to reduce transmission
- HAART (Highly Active Antiretroviral Therapy) - established in 2013 as the standard of care; very effective at prolonging life, improving quality of life, and reducing viral load, but does not cure HIV infection
PART 3: HERPESVIRUSES (Slides 19-60)
General Herpesvirus Properties (Slide 22)
All herpesviruses share these features:
- Icosahedral capsid surrounded by a lipoprotein envelope
- Linear double-stranded DNA genome
- Large: 120-200 nm in diameter
- Replicate inside the nucleus
- Form intranuclear inclusion bodies
- Get their envelope from the nuclear membrane (unusual!)
- Cause latent infections - after the acute disease, they become dormant but can reactivate
Herpesviruses are divided into three subfamilies:
| Subfamily | Members |
|---|
| α (Alpha) | HSV-1, HSV-2, VZV |
| β (Beta) | CMV (HHV-5), HHV-6, HHV-7 |
| γ (Gamma) | EBV (HHV-4), HHV-8 (KSHV) |
Latency Cycle (Slide 24)
- Hallmark of all herpesviruses
- Virus becomes dormant in specific host cells (neurons for HSV/VZV, B cells for EBV)
- Reactivates under stress, illness, sunlight, or immune suppression
- Upon reactivation, virus travels back to skin/mucosa causing recurrent lesions
A. HERPES SIMPLEX VIRUS (HSV) - Slides 25-34
Two types distinguished by antigenicity and location:
| Feature | HSV-1 | HSV-2 |
|---|
| Location | Above the waist | Below the waist |
| Transmission | Saliva | Sexual contact |
| Latency site | Trigeminal ganglia | Lumbar and sacral ganglia |
HSV-1 Clinical Diseases:
- Gingivostomatitis (primary, mainly in children): fever, irritability, painful vesicular lesions in the mouth; heals spontaneously in 2-3 weeks
- Herpes labialis (cold sores/fever blisters): recurrent crops of vesicles at lips or nose
- Keratoconjunctivitis: corneal ulcers and conjunctival lesions; recurrences can cause scarring and blindness
- Encephalitis: necrotic lesion in one temporal lobe, high mortality, severe neurologic sequelae in survivors
HSV-2 Clinical Diseases:
- Genital herpes: painful vesicular lesions of genitals and anal area; primary infections have fever and inguinal lymphadenopathy; asymptomatic infections occur in both sexes
- Neonatal herpes: acquired during birth from vesicular lesions in birth canal; can be prevented by cesarean section when active lesions or positive cultures are present
Diagnosis:
- Cell culture isolation (cytopathic effect in 1-3 days)
- Tzanck smear (Giemsa stain): shows multinucleated giant cells - presumptive diagnosis
- PCR of spinal fluid for encephalitis diagnosis
- Fluorescent antibody staining or ELISA for confirmation
Treatment:
- Acyclovir (Zovirax) - treatment of choice for encephalitis, systemic disease, neonatal HSV-2
- Also used for genital herpes (shortens duration, reduces shedding, but does not cure latency)
- Viroptic - topical for HSV-1 eye infection
- Prophylactic long-term acyclovir, valacyclovir, or famciclovir can suppress recurrences (but no drug eliminates the latent state)
B. VARICELLA-ZOSTER VIRUS (VZV) - Slides 35-39
- Varicella (chickenpox) = primary disease
- Zoster (shingles) = reactivation/recurrent disease
- Transmitted by respiratory droplets and direct contact with lesions
- Highly contagious childhood disease
Clinical Manifestations:
- Incubation period: 14-21 days
- Prodrome: fever and malaise, then headache
- Spots appear in crops, develop into itchy blisters anywhere on the body
- Zoster: painful vesicles along the course of a sensory nerve (head or trunk); in immunocompromised patients, can cause life-threatening disseminated pneumonia
Diagnosis & Treatment:
- Tzanck smear: multinucleated giant cells (same as HSV)
- Cell culture with specific antiserum
- No antiviral needed in immunocompetent children
- Acyclovir for immunocompromised; foscarnet for acyclovir-resistant strains
- Famciclovir (Famvir) and valacyclovir (Valtrex) also available
Vaccines:
| Vaccine | Target | Notes |
|---|
| Varivax | Prevent varicella | For children ages 1-12; 2 doses |
| Zostavax | Prevent zoster | For people >60 years; 1 dose; 14x more virus than Varivax |
| Both are live, attenuated VZV. Neither eradicates the latent state. | | |
C. CYTOMEGALOVIRUS (CMV) - Slides 40-44
- Also called HHV-5, a β-herpesvirus
- Named for its distinctive cytopathic effect: "owl's eye" intranuclear inclusions and cell enlargement (cytomegaly)
- Very common: >60-90% of adults worldwide are infected
Transmission: saliva, urine, blood, sexual contact, breast milk, organ transplants, and congenitally (in utero)
Clinical Presentations:
- Healthy adults: usually asymptomatic; occasionally mononucleosis or hepatitis
- Immunocompromised (transplant patients, HIV+): serious, life-threatening infections
- Congenital CMV (in newborns): rash, jaundice, microcephaly, IUGR, hepatosplenomegaly, seizures, retinitis; long-term: hearing loss, developmental/motor delay, vision loss, anemia, thrombocytopenia
Diagnosis: viral DNA or antigen detection in blood/fluids; virus isolation; IgM/IgG serology
Treatment:
- Ganciclovir (nucleoside analog, similar to acyclovir) - inhibits CMV replication
- Foscarnet (second-line)
- Cidofovir (nucleotide analog, third option)
D. EPSTEIN-BARR VIRUS (EBV) - Slides 45-54
- HHV-4, a γ-herpesvirus
- ~90-95% of adults worldwide are seropositive
- Transmitted via saliva ("kissing disease")
- Infects mainly B lymphocytes and pharyngeal epithelial cells
- In latently infected cells, EBV DNA is in the nucleus but not integrated into cellular DNA
Key Antigens:
- VCA (Viral Capsid Antigen) - most important; used most often diagnostically
- EA (Early Antigens) - produced before viral DNA synthesis
- EBNA (Nuclear Antigen) - diagnostically helpful
Diseases caused:
- Infectious Mononucleosis (IM) - fever, malaise, pharyngitis, tender lymphadenopathy, splenomegaly; lasts days to weeks; 1-5% develop complications (splenic rupture, encephalitis, hemolytic anemia)
- Burkitt Lymphoma (BL) - most common malignancy in young children in sub-Saharan Africa; rare, aggressive non-Hodgkin's lymphoma; linked to EBV + chronic malaria; symptoms include abdominal swelling, facial bone distortion, night sweats
- Nasopharyngeal Carcinoma (NPC)
- EBV can immortalize B-lymphocytes in vitro and in vivo
Diagnosis: Atypical lymphocytes + heterophile antibodies (monospot test); EBV-specific serology; liver function tests; splenomegaly on exam
Treatment: Largely supportive (>95% recover without intervention); restrict contact sports to prevent splenic rupture; acyclovir can reduce EBV replication in tissue culture
E. HHV-6 AND HHV-7 (Slides 55-57)
- β-herpesviruses; transmitted via saliva and breastfeeding
- Main target: T-lymphocytes (and B-lymphocytes)
- Ubiquitous worldwide
- HHV-6 and HHV-7 are related to each other similarly to HSV-1 and HSV-2
Primary HHV-6 disease: Roseola Infantum (Exanthem Subitum)
- Classical childhood disease; ages 4 months to 2 years
- Spiking high fever for 2 days → mild rash
- Fever high enough to cause febrile convulsions; may be complicated by encephalitis
Diagnosis: Clinical (characteristic presentation); serology (IgM and IgG) for confirmation
Treatment: No specific antiviral treatment available
F. HHV-8 (KSHV) (Slide 58)
- Human Herpesvirus 8, also called Kaposi's Sarcoma-Associated Herpesvirus (KSHV)
- Identified in 1994 from AIDS-associated Kaposi's sarcoma
- Belongs to the γ-herpesvirus subfamily
- Strongly associated with Kaposi's sarcoma in AIDS patients
PART 4: PRION DISEASES (Slides 61-68)
What Are Prions? (Slide 61)
Prions are unique infectious agents:
- Composed only of protein - no nucleic acids (no DNA or RNA genes)
- Impervious to standard microbial disinfection
- Diseases have very long incubation periods (up to 30 years)
- Can cause inherited, communicable, or sporadic diseases
- Affect both animals and humans
Transmission: via infected tissue, ingestion, cuts in skin, transplantation of contaminated tissues (e.g., cornea), and contaminated medical devices (e.g., brain electrodes)
Mechanism (Slide 63)
- A normal cellular gene PrP (on chromosome 20) encodes a normal protein designated PrPc
- This normal protein can be converted by a conformational change into a disease-causing form: PrPsc
- PrPsc is the actual prion - it can template the conversion of more normal PrPc proteins into PrPsc, causing a chain reaction
- PrPsc accumulates in the brain and causes disease
Pathology (Slide 65)
- These diseases are called Subacute Spongiform Encephalopathies (SSE) or Transmissible Spongiform Encephalopathies (TSE)
- Named "spongiform" because of vacuolar (sponge-like) changes in the cortex and cerebellum
- Pathological features: neuronal loss and astrocyte proliferation
- All are progressive and fatal
Specific Prion Diseases:
Kuru (Slide 66)
- Affected the Fore people of Eastern Highlands, New Guinea
- Mainly adult women and children of either sex
- Symptoms: ataxia, hyperreflexia, spasticity → progressive dementia → death
- Cause: Ritual cannibalism (eating brain soup of dead relatives)
- Incubation: 4-20 years after exposure
- Has disappeared since the elimination of cannibalism from the Fore culture
Creutzfeldt-Jakob Disease (CJD) (Slide 67)
- Progressive, fatal CNS illness; most common in the 6th and 7th decades of life
- Initial symptoms: change in cerebral function, often diagnosed initially as a psychiatric disorder
- Sporadic (85%) or familial (15%)
- Also transmitted by: dura mater grafts, corneal transplants, contaminated neurosurgical instruments, pituitary-derived growth hormone
- No effective therapy - all cases fatal
- Nosocomial infections preventable by careful sterilization
Bovine Spongiform Encephalopathy (BSE) / "Mad Cow Disease" (Slide 68)
- Identified in 1986 in the United Kingdom
- Cows became uncoordinated and unusually apprehensive
- Source: food supplement containing meat and bone meal from dead sheep
- The BSE prion survived cooking and was transmitted to humans who consumed infected bovine neural tissue or bone marrow (found in processed meats)
- Led to variant CJD (vCJD) in humans
- Destruction of diseased cattle and changes in livestock feeding have prevented further cases
Summary Table: Herpesviruses at a Glance
| Virus | HHV # | Subfamily | Primary Disease | Latency Site | Treatment |
|---|
| HSV-1 | HHV-1 | α | Cold sores, encephalitis | Trigeminal ganglia | Acyclovir |
| HSV-2 | HHV-2 | α | Genital herpes, neonatal herpes | Sacral ganglia | Acyclovir |
| VZV | HHV-3 | α | Chickenpox, Shingles | Dorsal root ganglia | Acyclovir |
| EBV | HHV-4 | γ | Mononucleosis, Burkitt lymphoma | B cells | Supportive |
| CMV | HHV-5 | β | Congenital infection, pneumonia in immunocompromised | Monocytes/macrophages | Ganciclovir |
| HHV-6 | HHV-6 | β | Roseola Infantum | T cells | None specific |
| HHV-7 | HHV-7 | β | Similar to HHV-6 | T cells | None specific |
| KSHV | HHV-8 | γ | Kaposi's Sarcoma | B cells | - |
This lecture covers the essential virology and clinical microbiology of three important groups - retroviruses (with HIV as the key human pathogen), herpesviruses (8 human types with distinct diseases), and prions (unconventional infectious protein agents). The recurring themes are latency and reactivation (herpesviruses), immune evasion and CD4 depletion (HIV), and protein misfolding and neurodegeneration (prions).